OCRFA has teamed up with Stand Up To Cancer and the National Ovarian Cancer Coalition (NOCC) to fund an Ovarian Cancer “Dream Team,” which is conducting a large-scale research project to help change the future of ovarian cancer. The project is being spearheaded by Alan D’Andrea, MD (Dana-Farber Cancer Institute) and Elizabeth Swisher, MD (University of Washington), a former recent member of the OCRFA Scientific Advisory Committee and also an OCRFA grantee.

The Ovarian Cancer Dream Team, which was announced on April 20, 2015, focuses on “DNA Repair Therapies for Ovarian Cancer,” building on recent advances that have identified DNA repair as a common weakness in ovarian cancer. Researchers will also explore the prevention and early detection of ovarian cancer by developing a web-based approach to genetic testing and counseling. Dream Team researchers hope to offer women identified as genetically high-risk a choice of surgical options, including one that removes the fallopian tubes but spares the ovaries. The Dream Team grant provides funding over a three-year period, which started in July 2015.

Elizabeth Swisher, MD
Elizabeth Swisher, MD
Alan D'Andrea, MD
Alan D’Andrea, MD

Led by Dr. D’Andrea and Dr. Swisher, the project also involves researchers at the Mayo Clinic, University of Chicago, University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. The Dream Team also includes three patient advocates: Kathleen Gavin, executive director of the Minnesota Ovarian Cancer Alliance; Sue Friedman, executive director of FORCE (Facing Our Risk of Cancer Empowered); and ovarian cancer survivor Jamie Crase.

Read the press release

Listen to Dr. Swisher’s webinar on the Ovarian Cancer Dream Team here.